# OnCo record sunesis (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/sunesis/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "sunesis" ;
  schema:name "Sunesis Pharmaceuticals"@en ;
  schema:alternateName "Sunesis Pharmaceuticals, Inc."@en, "Viracta Therapeutics"@en ;
  schema:description "Sunesis developed vosaroxin, a quinolone-derived cytotoxic that narrowly missed its survival endpoint in the phase 3 VALOR trial in relapsed acute myeloid leukaemia; the company later merged into Viracta."@en ;
  schema:url <https://onco.cc/companies/sunesis/>, <http://www.sunesis.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <http://www.sunesis.com>, <https://clinicaltrials.gov/search?lead=Sunesis%20Pharmaceuticals%2C%20Inc.>, <https://www.wikidata.org/wiki/Q7639948> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/aml/> ;
  onco:technologies <https://onco.cc/technologies/topoisomerase-inhibitors/> ;
  onco:terms <https://onco.cc/terms/pivotal-trial/>, <https://onco.cc/terms/clinical-trial/> .